Document Detail


Protective effect of dimethyl sulfoxide on acute myocardial infarction in rats.
MedLine Citation:
PMID:  19904216     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dimethyl sulfoxide (DMSO) is an organic compound widely used as solvent in biological studies and as vehicle for drug administration. DMSO has been shown to possess several biological effects, including antioxidant, anti-inflammatory, antinociceptive effects, and it has been proposed to be therapeutic in several disorders, such as gastrointestinal diseases, rheumatologic diseases, and for the treatment of several manifestations of amyloidosis. To better define the biological profile of DMSO, we investigated its effect on an in vivo model of acute myocardial infarction in rats, caused by left anterior descending coronary artery ligation. Our results show that pretreatment of rats with intraperitoneal (ip) DMSO (500 microL/Kg) for 3 consecutive days before left anterior descending coronary artery ligation significantly (P < 0.05) reduced cardiac damage from 18.75 +/- 4.88% (n = 12) to 4.46 +/- 2.01% (n = 8); serum levels of troponin I from 29.35 +/- 12.32 ng/mL (n = 8) to 2.95 +/- 1.32 ng/mL (n = 4); and serum levels of myoglobin from 46.86 +/- 10.35 ng/mL (n = 7) to 13.75 +/- 0.85 ng/mL (n = 4). Our data demonstrate that DMSO has a protective effect in a model of acute myocardial infarction in rats.
Authors:
Antonio Parisi; Alessio Alfieri; Marialuisa Mazzella; Antonio Mazzella; Mattia Scognamiglio; Gianluigi Scognamiglio; Nicola Mascolo; Carla Cicala
Related Documents :
10758976 - Evaluation of the effects of intramyocardial injection of dna expressing vascular endot...
9788826 - Differential expression of tissue inhibitors of metalloproteinases in the failing human...
10347796 - Differential effects of isoproterenol on the activity of angiotensin-converting enzyme ...
720476 - Determination of infarct size in rats with 86rubidium.
11406086 - Guidelines for the acute coronary syndromes.
17100106 - Drug-eluting stents: a pharmacoclinical perspective.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  55     ISSN:  1533-4023     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-22     Completed Date:  2010-04-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  106-9     Citation Subset:  IM    
Affiliation:
Dipartimento di Farmacologia Sperimentale, Universit? degli Studi di Napoli Federico II, Napoli, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antioxidants / pharmacology*
Dimethyl Sulfoxide / pharmacology*
Disease Models, Animal
Injections, Intraperitoneal
Male
Myocardial Infarction / drug therapy*,  physiopathology
Myoglobin / blood,  drug effects
Rats
Rats, Wistar
Troponin I / blood,  drug effects
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Myoglobin; 0/Troponin I; 67-68-5/Dimethyl Sulfoxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats w...
Next Document:  Can Helicobacter pylori invade human gastric mucosa?: an in vivo study using electron microscopy, im...